CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
parallel group to evaluate the efficacy and safety of autologous dendritic cell vaccination (ADCV01) as an add-on treatment for primary glioblastoma...
Phase 2
Taoyuan, Non-US, Taiwan and 2 other locations
A randomized, double-blind, placebo-controlled study. Weekly ADI-PEG 20 (36 mg/m2) or placebo will be combined with Stupp Protocol (Stupp 2005) radio...
Phase 2
Taipei City, Zhongzheng Dist, Taiwan and 9 other locations
with newly diagnosed glioblastoma....
Phase 1, Phase 2
Taoyuan City, Taiwan and 4 other locations
of this trial is to evaluate the effect of add-on JP001 to standard chemoradiation in increasing overall survival (OS) on newly diagnosed glioblastoma...
Phase 2, Phase 3
Taipei City, Taiwan and 1 other location
or without microbubble (MB)-mediated FUS in patients with recurrent GBM. BEV represents the physician's best choice for the standard of care...
Phase 3
Taipei, Taiwan and 1 other location
To assess:* efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification...
Phase 2
Taipei City, Taiwan and 90 other locations
Clinical trials
Research sites
Resources
Legal